Recombinant; Rabbit anti Human Progesterone Receptor Antibody; WB; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab123207-10μl | 10μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $56.90 | |
| Ab123207-50μl | 50μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $169.90 | |
| Ab123207-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $269.90 | |
| Ab123207-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,399.90 |
Recombinant; Rabbit anti Human Progesterone Receptor Antibody; WB; Unconjugated
| Product Name | Recombinant Progesterone Receptor Antibody - Primary antibody, specific to Progesterone Receptor, Rabbit IgG |
|---|---|
| Synonyms | NR3C3 antibody; Nuclear receptor subfamily 3 group C member 3 antibody; PGR antibody; PR antibody; PRA antibody; PRB antibody; PRGR_HUMAN antibody; Progesterone receptor antibody; Progestin receptor form A antibody; Progestin receptor form B antibody; NR3 |
| Specifications & Purity | ExactAb™, Validated, Recombinant, 0.5 mg/mL |
| Host species | Rabbit |
| Specificity | Progesterone Receptor |
| Immunogen | A synthetic peptide derived from human Progesterone Receptor (AA 1-49) |
| Positive Control | WB: MCF7 cell lysates. |
| Conjugation | Unconjugated |
| Grade | ExactAb™, Recombinant, Validated |
| Product Description |
Rabbit anti Human Progesterone Receptor Antibody, Recombinant, could be used for WB and so on. |
| Isotype | Rabbit IgG |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A purified |
| Form | Liquid |
| Concentration | 0.5 mg/mL |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Recombinant Progesterone Receptor Antibody (Ab123207) - Western Blot
All lanes: Recombinant Progesterone Receptor Antibody (Ab123207) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 99 kDa
Observed band size: 78, 110 kDa
Exposure time: 20.0 s
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Application | Dilution info |
|---|---|
| WB |
1/500-1/2000
|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0607090 | Certificate of Analysis | Jun 20, 2024 | Ab123207 |
| ZJ24F0607089 | Certificate of Analysis | Jun 20, 2024 | Ab123207 |
| 1. Qi C, Chang J, Zhu Y, Yeldandi AV, Rao SM, Zhu YJ. (2002) Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.. J Biol Chem, 277 (32): (28624-30). [PMID:12039952] |
| 2. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. (2000) The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.. Mol Cell Biol, 20 (9): (3102-15). [PMID:10757795] |
| 3. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.. EMBO J, 9 (5): (1603-14). [PMID:2328727] |
| 4. Li JJ, Iula DM, Nguyen MN, Hu LY, Dettling D, Johnson TR, Du DY, Shanmugasundaram V, Van Camp JA, Wang Z et al.. (2008) Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.. J Med Chem, 51 (21): (7010-4). [PMID:18921992] |
| 5. Hamann LG, Higuchi RI, Zhi L, Edwards JP, Wang XN, Marschke KB, Kong JW, Farmer LJ, Jones TK. (1998) Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.. J Med Chem, 41 (4): (623-39). [PMID:9484511] |
| 6. Rewinkel J, Enthoven M, Golstein I, van der Rijst M, Scholten A, van Tilborg M, de Weys D, Wisse J, Hamersma H. (2008) 11-(pyridinylphenyl)steroids--a new class of mixed-profile progesterone agonists/antagonists.. Bioorg Med Chem, 16 (6): (2753-63). [PMID:18243712] |
| 7. Fensome A, Adams WR, Adams AL, Berrodin TJ, Cohen J, Huselton C, Illenberger A, Kern JC, Hudak VA, Marella MA et al.. (2008) Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).. J Med Chem, 51 (6): (1861-73). [PMID:18318463] |
| 8. Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK. (2003) BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.. Mol Cell Biol, 23 (17): (6210-20). [PMID:12917342] |
| 9. Daniel AR, Faivre EJ, Lange CA. (2007) Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.. Mol Endocrinol, 21 (12): (2890-906). [PMID:17717077] |
| 10. Yudt MR, Russo LA, Berrodin TJ, Jelinsky SA, Ellis D, Cohen JC, Cooch N, Haglund E, Unwalla RJ, Fensome A et al.. (2011) Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.. Biochem Pharmacol, 82 (11): (1709-19). [PMID:21854761] |
| 11. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, Shin Y, Liu J, Cameron MD, Noel R et al.. (2012) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.. Nature, 485 (7396): (62-8). [PMID:22460951] |
| 12. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R. (2016) Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.. Eur J Med Chem, 109 (3): (216-37). [PMID:26774927] |
| 13. Piotrowski DW. (2012) Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy.. J Med Chem, 55 (18): (7957-66). [PMID:22866979] |
| 14. Chianelli D, Rucker PV, Roland J, Tully DC, Nelson J, Liu X, Bursulaya B, Hernandez ED, Wu J, Prashad M et al.. (2020) Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis.. J Med Chem, 63 (8): (3868-3880). [PMID:31940200] |
| 15. Granberg KL, Yuan ZQ, Lindmark B, Edman K, Kajanus J, Hogner A, Malmgren M, O'Mahony G, Nordqvist A, Lindberg J et al.. (2019) Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.. J Med Chem, 62 (3): (1385-1406). [PMID:30596500] |
| 16. Todd D Taylor,Hideki Noguchi,Yasushi Totoki,Atsushi Toyoda,Yoko Kuroki,Ken Dewar,Christine Lloyd,Takehiko Itoh,Tadayuki Takeda,Dae-Won Kim,Xinwei She,Karen F Barlow,Toby Bloom,Elspeth Bruford,Jean L Chang,Christina A Cuomo,Evan Eichler,Michael G FitzGerald,David B Jaffe,Kurt LaButti,Robert Nicol,Hong-Seog Park,Christopher Seaman,Carrie Sougnez,Xiaoping Yang,Andrew R Zimmer,Michael C Zody,Bruce W Birren,Chad Nusbaum,Asao Fujiyama,Masahira Hattori,Jane Rogers,Eric S Lander,Yoshiyuki Sakaki. (2006-03-24) Human chromosome 11 DNA sequence and analysis including novel gene identification.. Nature, 440 ((7083)): (497-500). [PMID:16554811] |
| 17. Huang Huang,Ying Yu,Zhenting Gao,Yong Zhang,Chenjing Li,Xing Xu,Hui Jin,Wenzhong Yan,Ruoqun Ma,Jin Zhu,Xu Shen,Hualiang Jiang,Lili Chen,Jian Li. (2012-08-07) Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists.. Journal of medicinal chemistry, 55 ((16)): (7037-7053). [PMID:22862148] |
| 18. Ojasoo T, Doré JC, Gilbert J, Raynaud JP.. (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.. J Med Chem, 31 (6): (1160-1169). [PMID:2897467] |
| 19. Salman M, Chamness GC.. (1991) A potential radioiodinated ligand for androgen receptor: 7 alpha-methyl-17 alpha-(2'-(E)-iodovinyl)-19-nortestosterone.. J Med Chem, 34 (3): (1019-1024). [PMID:2002446] |
| 20. Buckman BO, Bonasera TA, Kirschbaum KS, Welch MJ, Katzenellenbogen JA.. (1995) Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.. J Med Chem, 38 (2): (328-337). [PMID:7830275] |
| 21. Astles PC, Brealey C, Brown TJ, Facchini V, Handscombe C, Harris NV, McCarthy C, McLay IM, Porter B, Roach AG, Sargent C, Smith C, Walsh RJ.. (1998) Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives.. J Med Chem, 41 (15): (2732-2744). [PMID:9667964] |
| 22. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K.. (2000) Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.. J Med Chem, 43 (26): (5010-5016). [PMID:11150172] |
| 23. Elmore SW, Coghlan MJ, Anderson DD, Pratt JK, Green BE, Wang AX, Stashko MA, Lin CW, Tyree CM, Miner JN, Jacobson PB, Wilcox DM, Lane BC.. (2001) Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.. J Med Chem, 44 (25): (4481-4491). [PMID:11728194] |
| 24. Zhou D, Carlson KE, Katzenellenbogen JA, Welch MJ.. (2006) Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity.. J Med Chem, 49 (15): (4737-4744). [PMID:16854080] |
| 25. Rudolph J, Chen L, Majumdar D, Bullock WH, Burns M, Claus T, Dela Cruz FE, Daly M, Ehrgott FJ, Johnson JS, Livingston JN, Schoenleber RW, Shapiro J, Yang L, Tsutsumi M, Ma X.. (2007) Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.. J Med Chem, 50 (5): (984-1000). [PMID:17274610] |
| 26. Lin HR, Safo MK, Abraham DJ.. (2007) Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.. Bioorg Med Chem Lett, 17 (9): (2581-2589). [PMID:17337183] |
| 27. Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, Foster P, Li J, Pircher P, Petrowski M, Schulman I, Westin S, Wrobel J, Yan G, Bischoff E, Daige C, Mohan R.. (2009) Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).. J Med Chem, 52 (4): (904-907). [PMID:19159286] |
| 28. Kallander LS, Washburn DG, Hoang TH, Frazee JS, Stoy P, Johnson L, Lu Q, Hammond M, Barton LS, Patterson JR, Azzarano LM, Nagilla R, Madauss KP, Williams SP, Stewart EL, Duraiswami C, Grygielko ET, Xu X, Laping NJ, Bray JD, Thompson SK.. (2010) Improving the developability profile of pyrrolidine progesterone receptor partial agonists.. Bioorg Med Chem Lett, 20 (1): (371-374). [PMID:19926282] |
| 29. Zhou HB, Lee JH, Mayne CG, Carlson KE, Katzenellenbogen JA.. (2010) Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.. J Med Chem, 53 (8): (3349-3360). [PMID:20355713] |
| 30. Arhancet GB, Woodard SS, Iyanar K, Case BL, Woerndle R, Dietz JD, Garland DJ, Collins JT, Payne MA, Blinn JR, Pomposiello SI, Hu X, Heron MI, Huang HC, Lee LF.. (2010) Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.. J Med Chem, 53 (16): (5970-5978). [PMID:20672820] |
| 31. Meyers MJ, Arhancet GB, Hockerman SL, Chen X, Long SA, Mahoney MW, Rico JR, Garland DJ, Blinn JR, Collins JT, Yang S, Huang HC, McGee KF, Wendling JM, Dietz JD, Payne MA, Homer BL, Heron MI, Reitz DB, Hu X.. (2010) Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.. J Med Chem, 53 (16): (5979-6002). [PMID:20672822] |
| 32. Riether D, Harcken C, Razavi H, Kuzmich D, Gilmore T, Bentzien J, Pack EJ, Souza D, Nelson RM, Kukulka A, Fadra TN, Zuvela-Jelaska L, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Nabozny GH, Thomson DS.. (2010) Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.. J Med Chem, 53 (18): (6681-6698). [PMID:20735001] |
| 33. Richardson TI, Clarke CA, Yu KL, Yee YK, Bleisch TJ, Lopez JE, Jones SA, Hughes NE, Muehl BS, Lugar CW, Moore TL, Shetler PK, Zink RW, Osborne JJ, Montrose-Rafizadeh C, Patel N, Geiser AG, Galvin RJ, Dodge JA.. (2011) Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.. ACS Med Chem Lett, 2 (2): (148-153). [PMID:24900294] |
| 34. Betageri R, Gilmore T, Kuzmich D, Kirrane TM, Bentzien J, Wiedenmayer D, Bekkali Y, Regan J, Berry A, Latli B, Kukulka AJ, Fadra TN, Nelson RM, Goldrick S, Zuvela-Jelaska L, Souza D, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Lee H, Pack E, Harcken C, Nabozny G, Thomson DS.. (2011) Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.. Bioorg Med Chem Lett, 21 (22): (6842-6851). [PMID:21963986] |
| 35. Hasui T, Matsunaga N, Ora T, Ohyabu N, Nishigaki N, Imura Y, Igata Y, Matsui H, Motoyaji T, Tanaka T, Habuka N, Sogabe S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S.. (2011) Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.. J Med Chem, 54 (24): (8616-8631). [PMID:22074142] |
| 36. Caboni L, Kinsella GK, Blanco F, Fayne D, Jagoe WN, Carr M, Williams DC, Meegan MJ, Lloyd DG.. (2012) "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer.. J Med Chem, 55 (4): (1635-1644). [PMID:22280402] |
| 37. Liu W, Zhou J, Geng G, Shi Q, Sauriol F, Wu JH.. (2012) Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A.. J Med Chem, 55 (2): (971-975). [PMID:22175694] |
| 38. Razavi H, Riether D, Harcken C, Bentzien J, Dinallo RM, Souza D, Nelson RM, Kukulka A, Fadra-Khan TN, Pack EJ, Zuvela-Jelaska L, Pelletier J, Panzenbeck M, Torcellini CA, Proudfoot JR, Nabozny GH, Thomson DS.. (2014) Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.. Bioorg Med Chem Lett, 24 (8): (1934-1940). [PMID:24656565] |
| 39. Gege C, Schlüter T, Hoffmann T.. (2014) Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.. Bioorg Med Chem Lett, 24 (22): (5265-5267). [PMID:25305688] |
| 40. Lin HR.. (2014) Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists.. Bioorg Med Chem Lett, 24 (15): (3626-3632). [PMID:24915879] |
| 41. Levine PM, Garabedian MJ, Kirshenbaum K.. (2014) Targeting the androgen receptor with steroid conjugates.. J Med Chem, 57 (20): (8224-8237). [PMID:24936953] |
| 42. Li H, Ban F, Dalal K, Leblanc E, Frewin K, Ma D, Adomat H, Rennie PS, Cherkasov A.. (2014) Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor.. J Med Chem, 57 (15): (6458-6467). [PMID:25062331] |
| 43. Ullrich T, Sasmal S, Boorgu V, Pasagadi S, Cheera S, Rajagopalan S, Bhumireddy A, Shashikumar D, Chelur S, Belliappa C, Pandit C, Krishnamurthy N, Mukherjee S, Ramanathan A, Ghadiyaram C, Ramachandra M, Santos PG, Lagu B, Bock MG, Perrone MH, Weiler S, Keller H.. (2014) 3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration.. J Med Chem, 57 (17): (7396-7411). [PMID:25121964] |
| 44. Yang C, Balsells J, Chu HD, Cox JM, Crespo A, Ma X, Contino L, Brown P, Gao S, Zamlynny B, Wiltsie J, Clemas J, Lisnock J, Gibson J, Zhou G, Garcia-Calvo M, Bateman TJ, Tong V, Xu L, Crook M, Sinclair P, Shen HC.. (2015) Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists.. ACS Med Chem Lett, 6 (4): (461-465). [PMID:25941555] |
| 45. Lai A, Kahraman M, Govek S, Nagasawa J, Bonnefous C, Julien J, Douglas K, Sensintaffar J, Lu N, Lee KJ, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Moon MJ, Joseph JD, Darimont B, Brigham D, Grillot K, Heyman R, Rix PJ, Hager JH, Smith ND.. (2015) Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.. J Med Chem, 58 (12): (4888-4904). [PMID:25879485] |
| 46. Genin MJ, Bueno AB, Agejas Francisco J, Manninen PR, Bocchinfuso WP, Montrose-Rafizadeh C, Cannady EA, Jones TM, Stille JR, Raddad E, Reidy C, Cox A, Michael MD, Michael LF.. (2015) Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia.. J Med Chem, 58 (24): (9768-9772). [PMID:26568144] |
| 47. Hirata K, Kotoku M, Seki N, Maeba T, Maeda K, Hirashima S, Sakai T, Obika S, Hori A, Hase Y, Yamaguchi T, Katsuda Y, Hata T, Miyagawa N, Arita K, Nomura Y, Asahina K, Aratsu Y, Kamada M, Adachi T, Noguchi M, Doi S, Crowe P, Bradley E, Steensma R, Tao H, Fenn M, Babine R, Li X, Thacher S, Hashimoto H, Shiozaki M.. (2016) SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious RORγ Inhibitor.. ACS Med Chem Lett, 7 (1): (23-27). [PMID:26819660] |
| 48. Yang F, Snyder LB, Balakrishnan A, Brown JM, Sivarao DV, Easton A, Fernandes A, Gulianello M, Hanumegowda UM, Huang H, Huang Y, Jones KM, Li YW, Matchett M, Mattson G, Miller R, Santone KS, Senapati A, Shields EE, Simutis FJ, Westphal R, Whiterock VJ, Bronson JJ, Macor JE, Degnan AP.. (2016) Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.. ACS Med Chem Lett, 7 (3): (289-293). [PMID:26985317] |
| 49. Yamada A, Kazui Y, Yoshioka H, Tanatani A, Mori S, Kagechika H, Fujii S.. (2016) Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists.. ACS Med Chem Lett, 7 (12): (1028-1033). [PMID:27994732] |
| 50. Martín-Martínez M, Pérez-Gordillo FL, Álvarez de la Rosa D, Rodríguez Y, Gerona-Navarro G, González-Muñiz R, Zhou MM.. (2017) Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.. J Med Chem, 60 (7): (2629-2650). [PMID:28051871] |
| 51. Xie M, Zhao H, Liu Q, Zhu Y, Yin F, Liang Y, Jiang Y, Wang D, Hu K, Qin X, Wang Z, Wu Y, Xu N, Ye X, Wang T, Li Z.. (2017) Structural Basis of Inhibition of ERα-Coactivator Interaction by High-Affinity N-Terminus Isoaspartic Acid Tethered Helical Peptides.. J Med Chem, 60 (21): (8731-8740). [PMID:29045135] |
| 52. Piotrowski DW, Futatsugi K, Casimiro-Garcia A, Wei L, Sammons MF, Herr M, Jiao W, Lavergne SY, Coffey SB, Wright SW, Song K, Loria PM, Banker ME, Petersen DN, Bauman J.. (2018) Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists.. J Med Chem, 61 (3): (1086-1097). [PMID:29300474] |
| 53. Unwalla R, Mousseau JJ, Fadeyi OO, Choi C, Parris K, Hu B, Kenney T, Chippari S, McNally C, Vishwanathan K, Kilbourne E, Thompson C, Nagpal S, Wrobel J, Yudt M, Morris CA, Powell D, Gilbert AM, Chekler ELP.. (2017) Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.. J Med Chem, 60 (14): (6451-6457). [PMID:28696695] |
| 54. Carcache DA, Vulpetti A, Kallen J, Mattes H, Orain D, Stringer R, Vangrevelinghe E, Wolf RM, Kaupmann K, Ottl J, Dawson J, Cooke NG, Hoegenauer K, Billich A, Wagner J, Guntermann C, Hintermann S.. (2018) Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model.. J Med Chem, 61 (15): (6724-6735). [PMID:29990434] |
| 55. Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M.. (2018) Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.. ACS Med Chem Lett, 9 (7): (641-645). [PMID:30034593] |
| 56. Rew Y, Du X, Eksterowicz J, Zhou H, Jahchan N, Zhu L, Yan X, Kawai H, McGee LR, Medina JC, Huang T, Chen C, Zavorotinskaya T, Sutimantanapi D, Waszczuk J, Jackson E, Huang E, Ye Q, Fantin VR, Sun D.. (2018) Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).. J Med Chem, 61 (17): (7767-7784). [PMID:30091920] |
| 57. Lee JH, Dean M, Austin JR, Burdette JE, Murphy BT.. (2018) Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.. J Nat Prod, 81 (9): (1962-1967). [PMID:30199256] |
| 58. Dalal K, Morin H, Ban F, Shepherd A, Fernandez M, Tam KJ, Li H, LeBlanc E, Lack N, Prinz H, Rennie PS, Cherkasov A.. (2018) Small molecule-induced degradation of the full length and V7 truncated variant forms of human androgen receptor.. Eur J Med Chem, 157 (1164-1173). [PMID:30193215] |
| 59. Hoegenauer K, Kallen J, Jiménez-Núñez E, Strang R, Ertl P, Cooke NG, Hintermann S, Voegtle M, Betschart C, McKay DJJ, Wagner J, Ottl J, Beerli C, Billich A, Dawson J, Kaupmann K, Streiff M, Gobeau N, Harlfinger S, Stringer R, Guntermann C.. (2019) Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors.. J Med Chem, 62 (23): (10816-10832). [PMID:31729873] |
| 60. Kahraman M, Govek SP, Nagasawa JY, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Liu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Heyman R, Rix PJ, Hager JH, Smith ND.. (2019) Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927.. ACS Med Chem Lett, 10 (1): (50-55). [PMID:30655946] |
| 61. Passeri D, Carotti A, Pittol JMR, Ciaccioli G, Pellicciari R, van Mil SWC, Gioiello A.. (2019) Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.. Medchemcomm, 10 (8): (1412-1419). [PMID:31673308] |
| 62. Du X, Eksterowicz J, Zhou H, Rew Y, Zhu L, Yan X, Medina JC, Huang T, Chen X, Sutimantanapi D, Jahchan N, Kong W, Sun J, Zavorotinskaya T, Ye Q, Fantin VR, Sun D.. (2019) Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633).. J Med Chem, 62 (14): (6751-6764). [PMID:31274313] |
| 63. Hwang DJ, He Y, Ponnusamy S, Mohler ML, Thiyagarajan T, McEwan IJ, Narayanan R, Miller DD.. (2019) New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.. J Med Chem, 62 (2): (491-511). [PMID:30525603] |
| 64. He Y,Hwang DJ,Ponnusamy S,Thiyagarajan T,Mohler ML,Narayanan R,Miller DD. (2020) Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer.. J Med Chem, 63 (21): (12642-12665). [PMID:33095584] |
| 65. Pellicciari R,Passeri D,De Franco F,Mostarda S,Filipponi P,Colliva C,Gadaleta RM,Franco P,Carotti A,Macchiarulo A,Roda A,Moschetta A,Gioiello A. (2016) Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.. J Med Chem, 59 (19): (9201-9214). [PMID:27652492] |
| 66. Qin J,Qu S,Zhu K,Cheng Y,Pan G,Jing W,Liu X,Sun X,Liu L. (2021) Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers.. Bioorg Med Chem, 32 (116003-116003). [PMID:33461148] |
| 67. Dai,Y.; Yue,N.; Gong,J.; Liu,C.; Li,Q.; Zhou,J.; Huang,W.; Qian,H.. (2020) Development of cell-permeable peptide-based PROTACs targeting estrogen receptor α.. Eur J Med Chem, 187 (111967-111967). [PMID:31865016] |
| 68. Xie H,Liang JJ,Wang YL,Hu TX,Wang JY,Yang RH,Yan JK,Zhang QR,Xu X,Liu HM,Ke Y. (2020) The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader.. Eur J Med Chem, 204 (112512-112512). [PMID:32736229] |
| 69. Ing, N H NH, Beekman, J M JM, Tsai, S Y SY, Tsai, M J MJ and O'Malley, B W BW.. (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).. The Journal of biological chemistry, (5): [PMID:1517211] |
| 70. Misrahi, M M and 8 more authors.. (1987) Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA.. Biochemical and biophysical research communications, (13): [PMID:3551956] |
| 71. Huang, H F HF and Wang, M M.. (1994) [Effects of gossypol acetate, danazol, progesterone and GnRH-A on estrogen and progesterone receptors of human endometrial cells].. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, [PMID:8000225] |
| 72. Williams, S P SP and Sigler, P B PB.. (1998) Atomic structure of progesterone complexed with its receptor.. Nature, (28): [PMID:9620806] |
| 73. Sun, M M, Zhu, G G and Zhou, L L.. (1998) [Effect of mifepristone on the expression of progesterone receptor messenger RNA and protein in uterine leiomyomata].. Zhonghua fu chan ke za zhi, [PMID:10682471] |
| 74. Knotts, T A TA, Orkiszewski, R S RS, Cook, R G RG, Edwards, D P DP and Weigel, N L NL.. (2001) Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.. The Journal of biological chemistry, (16): [PMID:11110801] |
| 75. Hammond, G L GL, Rabe, T T and Wagner, J D JD.. (2001) Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.. American journal of obstetrics and gynecology, [PMID:11521119] |
| 76. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352] |
| 77. Jiang, J J, Wu, R R and Wang, Z Z.. (2001) [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].. Zhonghua fu chan ke za zhi, [PMID:11783365] |
| 78. Saner, Karla J KJ and 6 more authors.. (2003) Cloning and expression of a novel, truncated, progesterone receptor.. Molecular and cellular endocrinology, (28): [PMID:12644308] |
| 79. and Mokbel, K K.. (2003) Focus on anastrozole and breast cancer.. Current medical research and opinion, [PMID:14687437] |
| 80. and Sitruk-Ware, Régine R.. (2004) New progestogens: a review of their effects in perimenopausal and postmenopausal women.. Drugs & aging, [PMID:15493951] |
| 81. Pierson-Mullany, Lisa K LK and Lange, Carol A CA.. (2004) Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.. Molecular and cellular biology, [PMID:15572662] |
| 82. Schubert, Gerd G and 5 more authors.. (2005) Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).. Seminars in reproductive medicine, [PMID:15714390] |
| 83. Narayanan, Ramesh R, Edwards, Dean P DP and Weigel, Nancy L NL.. (2005) Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.. Molecular and cellular biology, [PMID:15798179] |
| 84. Chwalisz, Kristof K and 5 more authors.. (2005) Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.. Endocrine reviews, [PMID:15857972] |
| 85. Zhang, Zhiming Z and 15 more authors.. (2005) Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.. The Journal of biological chemistry, (5): [PMID:15937332] |
| 86. Chadli, Ahmed A and 8 more authors.. (2006) GCUNC-45 is a novel regulator for the progesterone receptor/hsp90 chaperoning pathway.. Molecular and cellular biology, [PMID:16478993] |
| 87. Risch, Harvey A HA, Bale, Allen E AE, Beck, Patricia A PA and Zheng, Wenxin W.. (2006) PGR +331 A/G and increased risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, [PMID:16985038] |
| 88. Arias-Loza, Paula Anahi PA and 11 more authors.. (2006) Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats.. Hypertension (Dallas, Tex. : 1979), [PMID:17000933] |
| 89. Gizard, Florence F and 8 more authors.. (2006) TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.. Molecular and cellular biology, [PMID:17015480] |
| 90. and Graziottin, Alessandra A.. (2006) A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch.. Treatments in endocrinology, [PMID:17107221] |
| 91. Tranguch, Susanne S, Smith, David F DF and Dey, Sudhansu K SK.. (2006) Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation.. Reproductive biomedicine online, [PMID:17169175] |
| 92. Daniel, Andrea R AR and 5 more authors.. (2007) Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.. Steroids, [PMID:17173941] |
| 93. Zhang, Pei-Jing PJ and 13 more authors.. (2007) CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.. The EMBO journal, (4): [PMID:17347654] |
| 94. Hompes, Peter G A PG and Mijatovic, Velja V.. (2007) Endometriosis: the way forward.. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, [PMID:17484506] |
| 95. Maruo, Takeshi T and 6 more authors.. (2007) Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.. Contraception, [PMID:17531625] |
| 96. Faivre, Emily J EJ, Daniel, Andrea R AR, Hillard, Christopher J CJ and Lange, Carol A CA.. (2008) Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.. Molecular endocrinology (Baltimore, Md.), [PMID:18202149] |
| 97. Chen, Caoyi C and 8 more authors.. (2008) The human progesterone receptor shows evidence of adaptive evolution associated with its ability to act as a transcription factor.. Molecular phylogenetics and evolution, [PMID:18375150] |
| 98. Vadivelu, Sudhakar S, Sharer, Leroy L and Schulder, Michael M.. (2010) Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.. Journal of neurosurgery, [PMID:19731987] |
| 99. and Pasqualini, Jorge R JR.. (2009) Breast cancer and steroid metabolizing enzymes: the role of progestogens.. Maturitas, [PMID:19962254] |
| 100. Pedram, Ali A, Razandi, Mahnaz M, Deschenes, Robert J RJ and Levin, Ellis R ER.. (2012) DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors.. Molecular biology of the cell, [PMID:22031296] |
| 101. Gemzell-Danielsson, Kristina K, Rabe, Thomas T and Cheng, Linan L.. (2013) Emergency contraception.. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, [PMID:23437846] |
| 102. Dai, Qunsheng Q and 9 more authors.. (2013) A truncated progesterone receptor (PR-M) localizes to the mitochondrion and controls cellular respiration.. Molecular endocrinology (Baltimore, Md.), [PMID:23518922] |
| 103. Okada, Hidetaka H, Tsuzuki, Tomoko T and Murata, Hiromi H.. (2018) Decidualization of the human endometrium.. Reproductive medicine and biology, [PMID:30013421] |
